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ABSTRACT
Genes encoding toxin–antitoxin (TA) systems are
near ubiquitous in bacterial genomes and they play
key roles in important aspects of bacterial physiol-
ogy, including genomic stability, formation of persis-
ter cells under antibiotic stress, and resistance to
phage infection. The CptIN locus from Eubacterium
rectale is a member of the recently-discovered Type
III class of TA systems, defined by a protein toxin
suppressed by direct interaction with a structured
RNA antitoxin. Here, we present the crystal structure
of the CptIN protein–RNA complex to 2.2 A˚ resolu-
tion. The structure reveals a new heterotetrameric
quaternary organization for the Type III TA class, and
the RNA antitoxin bears a novel structural feature
of an extended A-twist motif within the pseudoknot
fold. The retention of a conserved ribonuclease ac-
tive site as well as traits normally associated with TA
systems, such as plasmid maintenance, implicates
a wider functional role for Type III TA systems. We
present evidence for the co-variation of the Type III
component pair, highlighting a distinctive evolution-
ary process in which an enzyme and its substrate
co-evolve.
INTRODUCTION
Bacterial toxin–antitoxin (TA) systems were discovered
nearly 30 years ago in studies of plasmid stabilization dur-
ing cell division (1,2). Genes encoding TA systems are now
known to be very widespread in prokaryotic genomes (3).
TA systems have been classified into five types. All share
common features in that they include a toxic protein com-
ponent and are usually bicistronic in architecture, but are
distinguished from each other by the manner in which this
toxic protein is antagonized. In Type I systems, the anti-
toxin is an antisense RNA molecule that prevents transla-
tion of what is usually a small hydrophobic toxin. In Type II
systems the antitoxin is a co-expressed protein that directly
inhibits the toxin. Type IV and V TA systems also utilize
protein antitoxins; Type IV TA components do not phys-
ically interact and in the prototype system both proteins
act in opposing manners on a common substrate (4,5). The
single described Type V TA system employs a ribonuclease
antitoxin that targets the toxin transcript (6). The focus of
the present study, Type III systems, comprise a ribonuclease
(RNase) toxin that processes, and is then directly inhibited
by, its structured and specific cognate RNA antitoxin.
Recent advances in sequencing technology and the asso-
ciated exponential increase in available genomic data have
enabled large-scale bioinformatic surveys of TA loci, aimed
both at finding locations of known families and discover-
ing new TA families within the many open reading frames
(ORFs) of unknown function (7,8). As it became clear that
TA system loci are near-ubiquitous in bacterial genomes
(and often in very high numbers within a single species) the
definition of their role(s) in bacterial physiology became a
more pressing issue. TA systems have been associated with
multiple important phenotypes, including phage resistance,
maintenance of genomic islands and formation of bacterial
persister cells (9). The widespread distribution and redun-
dancy of the TA systems, especially in the Type II group,
*To whom correspondence should be addressed. Tel: +44 1223 333 642; Fax: +44 1223 766 108; Email: gpcs2@cam.ac.uk
†These authors contributed equally to the paper as first authors.
Present addresses:
Francesca L. Short, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, U.K.
Jarrod E. Voss, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia.
Tim R. Blower, School of Biological and Biomedical Sciences and Department of Chemistry, Durham University, Durham DH1 3LE, U.K.
Anastasia L. Orme, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, U.K.
Tom E. Whittaker, School of Mines Building, Imperial College London, London SW7 2BP, U.K.
C© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 at U
niversity of Cam
bridge on N
ovem
ber 27, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
9530 Nucleic Acids Research, 2015, Vol. 43, No. 19
suggests that TA pairs are important for organism fitness
(10–12).
The paradigmatic Type III TA locus, toxINPa, was dis-
covered on a cryptic plasmid of Pectobacterium atrosep-
ticum strain SCRI1039. A gene on this plasmid encoded a
homologue of a known phage resistance protein, and this
provided strong protection from some bacteriophages while
also being extremely toxic to the cell (13). This toxic gene
could only be cloned in concert with short tandem repeats
located upstream; these repeats were shown to encode a
small RNA that suppressed the activity of the toxin. The
components were named ToxNPa and ToxIPa (for Toxin
Inhibitor). Structural studies of toxINPa revealed that the
ToxNPa ribonuclease cleaved the repetitive ToxIPa RNA
into individual 36 base pseudoknot repeats, and then assem-
bled with these catalytic products into a heterohexameric,
triangular complex that inhibits the toxin (14). Interestingly,
ToxNPa was shown to be a distant structural homologue of
the Kid family of Type II TA system toxins.
The corresponding ToxINBt complex from Bacillus
thuringiensis showed a largely similar architecture to that
of P. atrosepticum, but with subtle structural changes that
underpinned highly specific TA recognition between cog-
nate partners (15). While the heterohexameric organization
of three ToxNs and three ToxIs was retained in this homo-
logue, the interface between the RNA and protein showed
key changes in the variable loops outside of the structural
core of the toxin that allow the selective recognition of its
cognate antitoxic RNA.
Over 120 putative Type III TA loci have been identified
bioinformatically, in very diverse bacterial species, and these
systems fall into three separate families (named ToxIN,
CptIN and TenpIN) based on sequence similarity of their
toxin components (16). While it is presumed that each locus
contains a structured RNA as its functional antitoxin, as
in the toxINPa paradigm, the tandem repeats differ greatly
in both primary sequence and length. Members of all three
families have been shown to function as TA loci, and at least
one other family (the TenpINs) can also mediate phage re-
sistance (16).
It has also become increasingly clear that RNA species
play a pivotal role in controlling gene expression in bacte-
ria (17). Since the realization of the importance of Hfq as a
regulator through its function as an RNA chaperone (18) as
well as the discovery of riboswitches (19), RNA is no longer
seen as a passive informational mediator. Similarly, the dis-
covery of systems of acquired phage immunity (CRISPR)
is another development that illuminates the ways in which
cellular proteins are able to directly use the information con-
tained within RNA species (20). While RNAs have been
postulated to be natural mediators of protein activity, based
on the precedent of artificial aptamers (21), most known ex-
amples show the RNA mimicking DNA (17). The distinc-
tive case in which ToxN is specifically regulated by a pseu-
doknot RNA species which the toxin itself processes is a
unique example in the growing repertoire of riboregulation
(14).
Here, we present the first structural investigation of a
member of the CptIN family of Type III TA systems.
Many Type III TA systems are plasmid-encoded (16) but we
decided to investigate the chromosomally-encoded CptIN
system, from the human commensal Eubacterium rectale
(CptINEr) as the first representative of the CptIN fam-
ily. CptINEr forms a dramatically different complex from
that of the previously described ToxIN systems, exhibiting
a unique oligomeric structure. We demonstrate that, while
CptIEr retains the pseudoknot core previously observed in
other Type III antitoxins, the extended length of the RNA
leads to the formation of unique tertiary features. However,
the overall principles of toxin inhibition are shared between
the CptIN and ToxIN families. The present study reveals
the structural diversity that can exist in these loci and high-
lights the remarkable case in which an enzyme co-evolves
with its cognate substrate.
MATERIALS AND METHODS
CptINEr purification, crystallization and structure determi-
nation
The ORF encoding CptNEr was cloned into pTYB1 (NEB)
using primers TRB273 and TRB274 (Table 2), with a three-
amino acid extension (LEG) to enable intein cleavage. The
CptIEr gene was cloned into pACYC184 (22) along with a
T7 promoter 3′ of the predicted start of the gene, identical
to that present in pTYB1, using the primers TRB271 and
TRB272 (Table 2). The resulting plasmids were introduced
to Escherichia coli ER2566 (NEB) by electroporation. For
native protein expression a 500 ml culture in 2×TY me-
dia was inoculated with an overnight culture of the expres-
sion strain at a 1:100 dilution and was grown at 37◦C to
OD600 0.8. The cells were then shifted to 18◦C, expression
of CptINEr was induced with a final concentration of 1 mM
IPTG, and expression was continued for 16 h. Expression of
the SeMet derivative was performed using a supplemented
minimal medium, as described (23). The cells were resus-
pended in 20 mMNa2HPO4, 500 mMNaCl, 1% v/v Triton
X-100, 1 mM ethylenediaminetetraacetic acid, pH 6.0 and
lysed by pressure with four passes through an EmulsiFlex-
C5 instrument at 10 000 psi. The CptINEr protein–RNA
complex was purified initially by passing the clarified lysate
through a chitin column followed by on-column cleavage
of the intein fragment fused to the CptNEr protein under
reducing alkaline conditions. The eluate from the cleavage
step was then fractionated by anion exchange chromatog-
raphy using a HiTrap Q 5 ml column (GE Healthcare),
yielding one sharp peak identified as the CptINEr complex.
The protein–RNA complex was then concentrated to ∼5
mg.ml−1 and used in crystallization trials.
Initial crystallization trials were carried out in 96-well
tray sitting drops of 200 nl of protein mixed with 200 nl
of precipitant in a vapour diffusion system with 200 l of
the precipitant in a reservoir, using the Classics, JCSG+
and Protein Complex commercial screens (Qiagen). Hits
were optimized using 24-well tray hanging drops of 1 l
of protein mixed with 1 l of precipitant with 500 l of
precipitant in the reservoir. The best diffracting crystals for
both the native and the SeMet derivative were from a con-
dition containing 200 mM CaCl2, 100 mM CH3CO2Na,
20%v/v 2-propanol, pH4.8.Data collectionwas performed
on the I-02 beamline at the Diamond Light Source syn-
chrotron facility (Harwell, Oxford, UK), with a single crys-
tal of the native complex diffracting to 2.2 A˚ and two crys-
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Table 1. Crystallographic and structural refinement data
Native SeMet
Diffraction Statistics
Space group P21 P21
Cell dimensions
a, b, c (A˚) 63.1, 185.9, 138.8 63.2, 186.5, 139.2
, ,  (◦) 90, 92.63, 90 90, 92.58, 90
Resolution (A˚) 2.2 (2.24–2.20) 3.0 (3.07–3.00)
Rmerge 0.048 (0.338) 0.164 (0.612)
I/I 11.6 (2.4) 13.9. (4.8)
Completeness (%) 97.9 (97.0) 100 (100)
Redundancy 2.3 (2.1) 13.5 (12.6)
Number of unique reflections 157 960 (7761) 64 337 (4487)
Wilson B factor (A˚2) 28.8 44.1
Refinement statistics
Rfactor 0.20
Rfree 0.23
Number of reflections used 161 398
Number of atoms
Protein 10409
RNA 7696
Ion 52
Water 1330
Average B factors
Protein 41.4
RNA 42.6
Ion 59.9
Water 39.8
Rmsd (bonds) 0.013
Rmsd (angles) 1.72
tals of the SeMet derivative, both of which diffracted to 3.0
A˚ (summarized in Table 1). Data processing and reduction
were performed on these datasets using iMOSFLM (24),
SCALA (25) and TRUNCATE (26) from the CCP4 suite
of programs (27). The combined SeMet data was input as
a single-wavelength anomalous dispersion (SAD) set into
the AutoSolve function in PHENIX (28), yielding a solu-
tion with 40 selenium sites (corresponding to eight protein
monomers) with a Figure of Merit of 0.385 and a read-
ily interpretable electron density map. It was noticed that
where there was obvious density corresponding to RNA,
protein residues had instead been placed by PHENIX. For
this reason, the prebuilt chains were removed and chain re-
traced using firstly BUCCANEER (29) for the protein and
then NAUTILUS (30) for the RNA. Manual chain build-
ing was continued using COOT (31), as well as the man-
ual addition of waters; very high positive peaks observed in
the FO-FC map showed the presence of Ca2+ ions from the
crystallization condition, also corroborated by the presence
of clear octahedral coordination from adjacent waters and
RNA phosphate groups. The model could then be directly
refined using REFMAC5 (32) against the isomorphous na-
tive dataset, and the final 2.2 A˚ structure contained eight
protein chains of CptNEr from residues 1 to 155, as well as
eight full 45 nt chains of the CptIEr RNA (with Ramachan-
dran statistics of 98.3% preferred, 1.6% allowed and 0.1%
outliers).
RNA structural searches
AMIGOS II (33) was used to calculate RNA torsional an-
gles and to perform structural searches. Structural searches
were performed using the ‘Worm search’ function on all
available RNA structures in the PDB.
Construction of CptIEr mutants
Overexpression vectors encoding either a single CptIEr re-
peat, or a mutated repeat, were constructed using a strategy
described previously (13), where a PCRwas performedwith
pQE-80L as the template, using PF185 together with a re-
verse primer encoding the repeat sequence. An additional
5′-GA and 3′-AAG was included at the boundaries of the
repeat to allow processing by CptNEr. Primer and plasmid
details are in Table 2.
CptI antitoxicity and cross-inhibition assays
Antitoxicity assays were performed in E. coli DH5 that
had been transformed with separately-inducible CptI and
CptN plasmids (Table 2). Assays were performed as de-
scribed previously (13,16).
Plasmid loss assays
Plasmid loss assays were performed in E. coli W3110 car-
rying either pFLS122 or pRBJ200 (Table 2). Experiments
were performed essentially as described (34), with non-
selective exponential growth maintained for 24 h.
RESULTS
CptINEr is a heterotetramer
The cptIN locus of E. rectale (Figure 1A) was previously
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Table 2. Strains, plasmids and primers used in this study
Strain Genotype Reference
Escherichia
coli DH5
F− −endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 80 lacZ M15 (lacZYA-argF) U169,
hsdR17(rK− mK+)
Invitrogen
E. coli
ER2566
F− −fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 (mcrC-mrr)114::IS10
R(mcr-73::miniTn10-TetS)2 R(zgb-210::Tn10)(TetS) endA1 [dcm]
NEB
E. coli
W3110
F− −rph-1 INV(rrnD, rrnE) (39)
Plasmid Description Source
pALO3 cptNEr in pTYB1 This study
pALO5 cptIEr with PT7 upstream in pACYC184 This study
pFLS104 cptIRt repeats and terminator in pTA100, SpR (16)
pFLS105 cptNRt in pBAD30, ApR (16)
pFLS106 cptICc repeats and terminator in pTA100, SpR (16)
pFLS107 cptNCc in pBAD30, ApR (16)
pFLS108 cptIEr repeats and terminator in pTA100, SpR (16)
pFLS109 cptNEr in pBAD30, ApR (16)
pFLS110 cptIEr single repeat in pTA100, SpR This study
pFLS111 cptIEr U30 single repeat in pTA100, SpR This study
pFLS112 cptIEr A29U single repeat in pTA100, SpR This study
pFLS122 cptINEr locus in pRBJ200, ApR This study
pRBJ200 E. coli par-deficient single-copy vector, ApR (40)
pTA100 SpR derivative of pQE-80L (13)
Primer Sequence 5’-3’* (Restriction site)
CptI-WT tttaagcttTCAACCCGACCATTTATATACCACATATCGGTCAGTGGTAAACTTtcaattgaatctat
tataattgtta (HindIII)
CptI-dU30 tttaagcttTCAACCCGACCATTTTATACCACATATCGGTCAGTGGTAAACTTtcaattgaatctattat
aattgtta (HindIII)
CptI-A29U ttaagcttTCAACCCGACCATTTAAATACCACATATCGGTCAGTGGTAAACTTtcaattgaatctatt
ataattgtta (HindIII)
PF185 AAACAAATAGGGGTTCCG
TRB271 TTGGATCCATAATCAGTATCACTGAGAAA (BamHI
TRB272 TTTCTAGAACTACGGCAAAAGACTTTTTC (XbaI)
TRB273 CCGGCATATGATAAGGAATGGTTTTTATATTATC (NdeI)
TRB274 GTGGTTGCTCTTCCGCACAAATGTGTTGCTGGTAAATC (SapI)
*For CptI primers, the region encoding the repeat is shown in uppercase.
shown to have TA function (16). To explore the structural
basis for this activity, and the extent to which its mechanism
is shared with ToxIN systems, the structure of the CptINEr
complex was solved by X-ray crystallography. CptIEr co-
purified with the CptNEr protein following overexpression
inE. coli, and the stable protein–RNA complex was crystal-
lized in both the native and SeMet forms. The best diffract-
ing crystals (1 native and 2 SeMet) were isomorphous, and,
following phasing through SAD, the final structure was
solved to a resolution of 2.2 A˚ (Table 1).
The unit cell contained a total of eight protein (CptNEr)
monomers each complexed with a single CptIEr RNA re-
peat of 45 nt. Examination of the symmetry units (Sup-
plementary Figure S1) reveals that each protein–RNA
heterodimer formed a self-closing, heterotetrameric ring-
shaped complex with a heterodimer from the neighbour-
ing asymmetric unit (Figure 1B). The idea that the biolog-
ical CptIN complex was the heterotetramer (of two pro-
tein monomers and two RNA ligands) observed in the
crystal structure was corroborated by analytical size exclu-
sion chromatography (Supplementary Figure S2 and Table
S1). Note that both crystallization and size exclusion chro-
matography use high concentrations of CptN and CptI; the
concentration of these molecules in the cell is unknown,
and complex assembly may be strongly influenced by the
turnover of these components and their interactions with
other molecules. Studies on a homologous system found
that the results from gel filtration could be further cor-
roborated by analytical ultracentrifugation. The heterote-
trameric architecture is a major deviation from the het-
erohexameric complexes formed by the other structurally-
defined Type III TA systems.
The structural core of the CptN protein is similar to the
structures of the three previously solved Type III toxins, be-
ing made up of a highly twisted antiparallel -sheet (Fig-
ure 1C). This is surrounded by four -helices, which, along
with the many loops in the structure, make extensive con-
tacts with the cognate RNA (Figure 1B). Of note is the ab-
sence of the kink in the third helix that is seen in the struc-
tures of ToxNPa (14), ToxNBt (15) and AbiQ (35); the equiv-
alent helix H4 in CptNEr is visibly shorter in comparison
(Figure 1C and D) and, as a result, CptNEr more closely
resembles the structure of the Type II Toxin Kid.
Each CptNEr protein binds two CptIEr RNAs, and the
protein–RNA interfaces are considerable for both. Inter-
face 1, which connects the protein to the 5′ end of the RNA,
is the larger of the two and spans over 1250 A˚2 (Figure 2A).
Of note here is the strong electropositive tract (shown in
blue) created by the RNA-facing side of helix H3, stabiliz-
ing the phosphate backbone and allowing the bases to stack
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Figure 1. The crystal structure of CptINEr to 2.2A˚ resolution. (A) The architecture of the CptINEr locus, showing the tandem repeats upstream of the
toxic CptNEr ORF that become processed into CptIEr monomers. (B) When analysed with symmetry cells in conjunction with data from size exclusion
chromatography, the biological unit was found to be a heterotetramer––an oval structure with two proteinmonomers at the poles (CptNEr) held together by
two pseudoknotted RNAs (CptIEr). The surface representation shows the electrostatic potential (red: electronegative, blue: electropositive. (PDB: 4RMO)
(C) The structural core of the protein is a highly twisted -sheet surrounded by -helices. (D) The overlay with carbon- traces of ToxNPa (magenta, PDB:
2XDD) and Kid, a Type II RNase (cyan, PDB: 1M1F), shows the lack of the kinked helix seen in ToxNPa in CptNEr, but still an overall similarity in fold.
and face into the protein. Also of note are the bases U4 and
C6, which do not stack with adjacent bases, but are instead
bound in hydrophobic pockets (residues Ile60, Ile74, Leu88
and Ile73, Val129, Phe139, Met132 respectively) that would
otherwise be exposed to solvent. Interface 2, which spans an
area of just over 1000 A˚2, is made up of largely polar con-
tacts between the protein and exposed bases at the 3′ end
of CptIEr (Figure 2B). A predicted hydrophobic interaction
with Ile106 presumably helps to stabilize the proximal end
of the S2 duplex, and the Tyr104 residue appears to be im-
portant both in helping to stabilize the position of the scis-
sile A45 nucleotide, as well as stacking onto G44.
The angle that the protein component makes with the
antitoxin strands is related to the quaternary state as it
forces the complex into a particular geometry; the angle
that CptIEr makes with CptNEr is significantly smaller than
that between ToxI and ToxN (Figure 3), and the number
of amino acid residues that are involved in contacting the
RNA ligand is high.
The CptIEr RNA is an H-type pseudoknot with a functionally
important extended A-minor twist and no major groove loop
The CptIEr RNA observed bound to CptNEr is a classic H-
type pseudoknot of 45 nt, which is derived from the two
genetic cptIEr repeats. The CptIEr pseudoknot comprises
two coaxial stem (base-paired) regions S1 and S2, with two
loops L1 and L2, with L1 being extremely short (one base),
and a much longer L2 loop (Figure 4A). The previously-
solved Type III antitoxin structures––the ToxI RNAs from
Pectobacterium and Bacillus (14,15)––were found to form
very similarH-type pseudoknots, and the tertiary structures
of both were maintained by intricate triplex interactions
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Figure 2. Diversity in the two protein–RNA interfaces in CptINEr. (A)
The surface representation shows the electrostatic potential (red: elec-
tronegative, blue: electropositive. Interface 1 is dominated by a long elec-
tropositive tract created by helix H3 interacting with the phosphate back-
bone, as well as the stabilization of U4 and C6 by a hydrophobic groove
created through the labelled side chains. (B) Interface 2 lacks any dominant
electropositive surface from the protein and is instead formed through a
number of specific polar interactions with hydrophilic residues on the out-
side of the protein. Key residues are labelled and shown as sticks, with
hydrogen bonds shown as black dashed lines. An important hydrophobic
interaction is made to the proximal end of the RNA duplex by Ile106.
(which were largely conserved between the two antitoxins)
between their loop sections and the associated stems. While
the Pectobacterium and Bacillus ToxI structures are very
similar to each other, the fold of the CptIEr differs markedly
from the ToxI paradigm, and is also structurally extremely
unusual among known RNA pseudoknots notably in the
structure of the loops.
In most pseudoknots the L1 loop interacts with the ma-
jor groove of the S2 helix, and L2 interacts with the mi-
nor groove of the S1 helix. This topology often leads to the
triplex interactions seen in many pseudoknots. In CptIEr,
the single base that forms the L1 loop, G13, does not inter-
act with the major groove of S2 at all and is held in place
by base stacking with the 3′ end of the L2 loop (G35), at
the same time forming some unique intra-chain hydrogen
bonds (Figure 4B). The L2 loop (A27-G35) in CptIEr is
much longer than those of the ToxIs, and is very A-rich.
Whilst L2 follows the classical association with the minor
groove of S1, the details of the interaction are not standard
(Figures 4C and 5). L2 forms a short, three-stranded helix
which has been previously referred to as an A-minor twist
motif (21). In other RNA species, the widely occurring A-
minor motif involves interaction between an unpaired ade-
nine base with the minor groove of an RNA duplex, usually
involving interactions with both the exposed bases in the
groove as well as the RNA backbone. A-minor twist motifs
can be seen as extensions of the classical A-minor types and
were first seen in the SAM-II riboswitch (36) and as part of
the glmS ribozyme structure (37). Both structures reported
a series of adenine bases associated with the minor groove
of a duplex at an angle of ∼70◦ with respect to the du-
plex helical axis. The L2 loop in CptIEr is similar, but, being
far longer than either of the previously described A-minor
twists, shows further detail as to how this motif can be ex-
tended. The motifs in the SAM-II riboswitch and in glmS
were shown to rotate around the helix clockwise. Similarly,
the section of the loop marked L2b (A31-G35) also rotates
around S1 in a clockwise manner (Figure 4C), with the po-
lar interactions surrounding one particular nucleotide, A33,
and the similarity of these interactions to those surround-
ingA37 in the riboswitch structure reflecting this (Figure 5C
andD). As well as the nature of the interactions being made
with multiple ‘tiers’ of the S1 duplex, a number of interest-
ing features of L2b should be noted, including the intricate
hydrogen bond network centred on the 2′ hydroxyl oxygen
atoms of A33 and U23, as well as an unusual interaction
between the 4′ oxygen of A33 and the 2′ hydroxyl of G24
(Figure 5A and C).
In contrast to L2b, L2a (A27–A29) is a counter-clockwise
twist of 3 nt with its own unique set of polar interactions
(Figure 5A); this displays an equally extended network of
hydrogen bonds as exemplified by the schematic shown for
the nucleotide A29 (Figure 5B). Of note is the fact that
this counter-clockwise twist was not seen adjacent to the
A-minor twist in glmS or the SAM-II riboswitch. To deter-
mine whether this counter-clockwise twist had been seen in
any previously published RNA structures, a search was per-
formed using the calculated torsional angles (Supplemen-
tary Table S2) for nucleotides A27–A29. No examples of
nucleotide stretches with similar torsional angles (total de-
viation<40) that also interacted with the minor groove of a
double helix were found in any previously described RNA
structure. This suggests that the counter-clockwise A-minor
twist is a novel motif.
A schematic of all the interactions in the CptI A-minor
twist summarizes the extensive network encompassing the
entirety of L2 (Figure 5A). The only bases that do not par-
ticipate in the network directly are U30, which faces out-
wards (and thereforemakes no polar contacts with the pseu-
doknot itself) but is instrumental in changing the direction-
ality of the twist, and G35, which appears to not make any
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Figure 3. The heterotetrameric quaternary structure and the geometry of the bound RNA. (A) It can be seen that the incoming and outgoing RNA strands
in CptINEr are completely parallel, driven by a much more extensive single stranded region at both the 5′ and 3′ ends of CptIEr looping into the protein.
(B) In ToxINPa, the interfaces are much more direct in relation to the ToxIPa duplex, creating a 60◦ angle between adjacent ToxIPa strands, leading to the
formation of a heterohexamer.
Figure 4. CptIEr is anH-Type pseudoknot with unique features in its L1 andL2 loop regions. (A) Left: a coloured schematic of CptIEr showing its two stems
(S1 and S2), and two loop regions (L1 and L2); right: a representation of the schematic on a cartoon of a single CptIEr monomer. (B) A close-up of the L1
loop region, unique in its dissociation with the stems altogether. It instead stacks with the proximal end of the L2 loop. (C) Close-up cartoon representations
of the L2 loop region (brown), which can be divided into two halves––L2a and L2b. Above: the upper half (L2a) is a unique counterclockwise A-minor
twist; below: the lower half (L2b) is a clockwise A-minor twist, with the change in directionality mediated by the ‘kink’ nucleotide (U30, teal).
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Figure 5. The A-minor twist motif is stabilized by extensive, multi-tiered, hydrogen bond networks and is required for antitoxicity. (A) A schematic of
the complex and interactions observed in the A-minor twist motif seen in isolation from the rest of the pseudoknot. Purple dashes represent unusual
polar interactions with no known notation, representing interactions involving the O3’ or O4’ of the ribose sugar. (B) Interactions in the counterclockwise
A-minor twist are dominated by interactions with the backbone of the red half of the stem (A7–10). Black dashes represent hydrogen bonds. The U30
kink nucleotide is again highlighted here in yellow. (C) The opposite is seen in the clockwise A-minor twist, where the strongest networks are formed on
the green half of the stem (G22–24). (D) An identical network can be seen in a previously identified A-minor motif in an unrelated structured RNA, the
SAM-II riboswitch (PDB: 2QWY). (E) Growth of Escherichia coli DH5 strains overexpressing CptNEr and CptIEr. Overexpression of CptNEr prevents
growth, which is rescued by co-overexpression of the full series of CptIEr repeats. A single CptIEr repeat, corresponding to the processed unit observed in
the crystal structure, shows full antitoxicity. However, mutants CptIEr-A29U and CptIEr-U30 are unable to counteract the toxicity of CptNEr. Results
shown are mean ± standard deviation for three biological replicates.
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interactions with the minor groove itself yet stacks with the
rest of the bases in the twist, and acts to bridge the twist
with the sole L1 nucleotide, G13 (Figure 4B). In both the
reported examples of A-minor twist motifs (36,37), the seg-
ment was small. However, the potential for it to be length-
ened further with the aid of a ‘kink’ nucleotide such as U30,
as shown here, reveals the capacity for the A-minor twist
to be extended into a dominant structural feature. To test
the functional significance of the extended A-minor twist,
site-directed mutants of CptIEr were tested for antitoxic-
ity against CptNEr (Figure 5E). As shown, deletion of the
‘kink’ nucleotide U30, or substitution of the adjacent A29
for U, rendered CptIEr unable to rescue the growth inhi-
bition caused by CptNEr. This result suggests that the ex-
tended A-minor twist seen in the structure is important for
CptIEr function, and that the structural integrity of this fea-
ture depends on the presence of a ‘kink’ nucleotide to fa-
cilitate a change of direction of the twist, and on extensive
hydrogen-bonding between A29 and the RNA duplex to
stabilize the counter-clockwise portion of this motif.
CptI RNAs show selective antitoxicity
The nature of the interactions observed at the protein–
RNA interfaces of the CptIN complex suggested that an-
titoxin recognition within this family would be highly spe-
cific, as precise CptI–CptN contacts would be needed to
maintain the inactive complex. To explore this hypothesis,
cross-inhibition experiments between CptINEr components
and the toxin and antitoxin components of the two other
validated Type III TA systems of the CptIN family were
performed. The three CptIN systems (CptINEr; CptINRt
from Ruminococcus torques L2–14; and CptINCc from Co-
prococcus catus GD-7) share a common locus organization
and 35–44% sequence identity between their toxin compo-
nents. Expression of any of the three CptN toxins was suf-
ficient to cause a dramatic drop in viable count, and this
was restored by co-overexpression of the cognate CptI anti-
toxin (Figure 6). Antitoxicity was not observed in any of the
six strains expressing non-cognate CptI and CptN combi-
nations. CptI RNA antitoxins are therefore highly selective
toxin inhibitors. This exquisite selectivity was also observed
in the ToxIN family (15) and supports the hypothesis that
the enzyme and its substrate have co-evolved as a mutually
compensating pair.
The active site of CptNEr is conserved with ToxN toxins
The RNA chains seen in the CptIN complex structure each
correspond to single repeats from the repetitive CptI se-
quence and a cyclic phosphate is seen at the 3′ end of each
RNA chain on the A45 nucleotide (Figure 7); these obser-
vations indicate that the CptN protein is, like ToxN, a ri-
bonuclease that processes its own antitoxin. Although there
is very little primary sequence identity between CptNEr and
any of the ToxNs, the hydrogen bonding networks in their
RNase active sites are well conserved. However, some devi-
ations can be seen. One is the use of two serine residues in
the conserved triad of [Ser]-[Ser/Thr]-[Arg] instead of thre-
onine as in the ToxNs. Another is in the group of residues
specifying the adenine base at the site of cleavage: the co-
ordinating glutamine is instead replaced by two residues
Figure 6. CptN toxins are specific for their cognate CptI antitoxins.
Kill/rescue assay with different combinations of CptI and CptN. All three
toxins could be neutralized by their cognate antitoxin, but not by the non-
cognate CptIs. Results shown are mean ± standard deviation for three bi-
ological replicates.
(Asp81 and Ser85), and the coordinating tyrosine (Tyr104)
approaches from below the plane of the base as depicted,
instead of above, as in the ToxN structures. This position-
ing also stabilizes the entry of the RNA by stacking with
G44, as described above. The combined evidence from the
structures of, now, three active sites in complex with their
RNA products suggest a catalytic mechanism that is similar
to that seen in Ribonuclease A (38), with the residues men-
tioned conserved specifically to stabilize the generation of
the cyclic phosphate. A similar mechanism was postulated
in the resolution of the AbiQ structure (35).
The TA locus CptIN stabilizes plasmids, but does not abort
phage infection in E. coli
Type III TA systems of the ToxIN family have roles in bac-
teriophage resistance and plasmid stabilization (13,15,35).
The cptINEr locus was therefore tested for capacity to con-
fer these phenotypes on a bacterial host. In the absence of
known Eubacterium phages, we assessed impacts on phage
of the CptINEr system reconstituted in E. coli. To exam-
ine bacteriophage resistance, an E. coli strain expressing
CptINEr was screened with over 200 environmentally iso-
lated ‘virgin’ coliphages. However, no difference was seen in
the plaque forming ability of these phages in comparison to
the control strain without plasmid. To explore plasmid sta-
bilization by cptINEr, plasmid loss assays were performed in
E. coliW3110 over the course of 24 h. As shown (Figure 8),
the test vector was lost from ∼50% of the cells over this pe-
riod, while the presence of cptINEr increased plasmid reten-
tion in the E. coli population to 100%. Although cptINEr is
located on the chromosome in the original host, we suggest
that its plasmid stabilization property is likely to also pro-
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Figure 7. A conserved active site and mechanism for the RNase activity of CptNEr. (A) A stick representation of the active site residues surrounding the
scissile adenine base (A45). Of note is Tyr104 which appears instrumental in both specifying for the adenine, as well as stacking onto the adjacent bases.
(B and C) Show similar representations of the active sites from ToxNPa and ToxNBt, showing a conserved mechanism and hydrogen bond cage, despite
significant primary sequence differences elsewhere.
Figure 8. CptINEr stabilizes plasmids in vivo. Proportion of plasmid-
containing Escherichia coliW3110 cells before (white) or after (grey) 24 h
of non-selective exponential growth. Results shown are mean ± standard
deviation for three biological replicates.
mote its retention in E. rectale and in other hosts that may
receive this locus through horizontal transfer.
DISCUSSION
The present work is the first structural study of a new family
of Type III loci, the CptINs, originally identified in a bioin-
formatics search for the distribution of Type III TA systems.
With the precedent set by the ToxIN system structures (the
twoToxINs fromPectobacterium (14) andBacillus (15), and
the AbiQ structure from Lactococcus (35)) of the formation
of a heterohexameric triangular oligomer, it was expected
that the CptIN and TenpIN families would also exhibit this
complex common architecture; indeed the other Type III
families were found using the structure of ToxNPa as the
initial seed in the bioinformatic search (16).
Unexpectedly, the CptINEr structure solved here forms a
heterotetrameric complex (Figure 1B), which was validated
by analytical size exclusion chromatography (Supplemen-
tary Figure S1). While the biological reason behind the dif-
fering organization of the tetrameric and hexameric Type
III TA systems remains unknown, it is not unreasonable to
suggest that their respective quaternary structures may play
a role in their relative stabilities within the cell. A higher
order complex necessitates a greater entropic penalty in its
formation and thus may be more likely to be disrupted and
dissociate in the cell.
The CptIEr structure adds evidence to the now increasing
perception that RNA molecules, like proteins, can form di-
verse structures to meet requirements for molecular recog-
nition (17). TheA-minor triple helix in the formof two adja-
cent A-minor twist motifs (Figures 4 and 5) is truly remark-
able in the multiple levels of interactions that are formed in
order to stabilize the duplex, and along with it, the pseu-
doknot itself. The occurrence of the A-minor twist in the
SAM-II riboswitch lends strength to the idea that there are
a limited number ofRNA folds used in nature.With all Type
III antitoxins to date found to have a pseudoknot structure,
it could be that the features of pseudoknots are both suf-
ficient and necessary for its functionality; the complex in-
tramolecular interactions allow for the generation of a large
interacting surface, while the single stranded nature of the
5′ and 3′ ends allow for processing by a co-factor. Nonethe-
less, taking into account the number of unusual interactions
seen (hydrogen bonding to the 3′ and 4′ ribose oxygens), this
CptIEr structure illustrates the variety of intra-strand RNA
interactions that can occur.
This particular structure also raises some interesting
questions regarding the evolution of the Type III TA sys-
tems. The conservation of the cage of residues in the active
site shows the importance of this core to the toxic func-
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tion of the system, but the low primary sequence identity
(<15% between CptNEr to either of the ToxNs) overall im-
plies a high degree of malleability when nucleating the sec-
ondary structure around it. The three Type III families seen
appear to therefore represent three energetically favourable
‘solutions’ to forming this protein–RNA complex. The lack
of cross-reactivity between even extremely similar antitoxin
RNAs (Figure 6) show that anything that would disrupt the
TA associationwhilemaintaining toxicity should ultimately
lead to a lower fitness for the cell. It therefore seems that any
deleterious mutation in one component must be compen-
sated by mutation in the same or partner component. As
one component is an enzyme and the other the target sub-
strate, this system represents a distinctive case in molecular
evolution in which substrates co-vary with the enzyme.
Functionally, there are still many mysteries surrounding
TA systems. The plasmid stabilization shows the selfish na-
ture of these loci, independent of host context. While no
phage resistance was seen in the experiments conducted in
E. coli, the fact that such structural diversity is seen, even
with the integrity of the TA functionality being so critical,
hints at the importance of these loci in bacterial physiology.
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